{"entity":{"id":"target-trial-emulation","kind":"term","name":"Target-trial emulation","aka":["emulated target trial","target trial framework"],"tldr":"An observational study can first describe the trial it is trying to approximate. This makes its treatment comparison and remaining assumptions easier to examine.","summary":"The primary target-trial framework makes the hypothetical randomized comparison explicit before analyzing observational data. Eligibility, strategies, assignment, follow-up, outcomes and analysis need to answer the same question. This structure helps identify timing and selection problems. It does not create randomization or remove unmeasured confounding simply because a study uses the label emulation.","asOf":"2026-11-08","links":[{"label":"Primary target-trial emulation framework (2016)","url":"https://doi.org/10.1093/aje/kwv254"}],"tags":[],"related":["real-world-evidence","confounding-by-indication","immortal-time-bias","estimand"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"category":"Trials"},"route":"/terms/target-trial-emulation/","neighbours":{"term":[{"id":"confounding-by-indication","kind":"term","name":"Confounding by indication","route":"/terms/confounding-by-indication/"},{"id":"estimand","kind":"term","name":"Estimands and intercurrent events (ICH E9(R1))","route":"/terms/estimand/"},{"id":"measurement-to-benefit-evidence","kind":"term","name":"Evidence from measurement to patient benefit","route":"/terms/measurement-to-benefit-evidence/"},{"id":"immortal-time-bias","kind":"term","name":"Immortal time bias","route":"/terms/immortal-time-bias/"},{"id":"real-world-evidence","kind":"term","name":"Real-world evidence","route":"/terms/real-world-evidence/"}]}}